The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Genentech (Inst)
Two doses of polatuzumab vedotin (PoV, anti-CD79b antibody-drug conjugate) in patients (pts) with relapsed/refractory (RR) follicular lymphoma (FL): Durable responses at lower dose level.
 
Ranjana H. Advani
Honoraria - Eisai; GE Healthcare; Millennium
Research Funding - Agensys (Inst); Allos Therapeutics (Inst); Celgene (Inst); Genentech/Roche (Inst); Idera (Inst); Janssen (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Genentech; Seagen
 
Ian Flinn
Research Funding - Genentech (Inst)
 
Jeff Porter Sharman
Research Funding - Genentech (Inst)
 
Catherine S. Magid Diefenbach
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Celgene; Idera; Immunogen; Immunogen; Janssen Oncology; Seagen
Speakers' Bureau - Gilead Sciences; Seagen
Research Funding - Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Molecular Templates (Inst); Seagen (Inst)
 
Kathryn S. Kolibaba
Research Funding - Genentech (Inst)
 
Oliver W. Press
Stock and Other Ownership Interests - Emergent Biosolutions; PhaseRx
Consulting or Advisory Role - Adaptive Biotechnologies; Algeta ASA; BIND Biosciences; Roche
Research Funding - Genentech (Inst); Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Algeta ASA; Roche
 
Laurie Helen Sehn
Research Funding - Genentech (Inst)
 
Andy I. Chen
Consulting or Advisory Role - Genentech
Research Funding - Genentech (Inst)
 
Gilles A. Salles
Honoraria - Amgen; Mundipharma; Roche/Genentech; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Mundipharma; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Herve Tilly
Honoraria - Celgene; Janssen; Roche/Genentech
Consulting or Advisory Role - Immunogen; Spectrum Pharmaceuticals; Takeda
Research Funding - Celgene (Inst)
 
Bruce D. Cheson
Research Funding - Genentech (Inst)
 
Sarit E. Assouline
Research Funding - Genentech (Inst)
 
Martin H. Dreyling
Honoraria - Roche/Genentech
Research Funding - Roche/Genentech (Inst)
 
Anton Hagenbeek
Research Funding - Genentech (Inst)
 
Pier Luigi Zinzani
No Relationships to Disclose
 
Cheryl Jones
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Yu-Waye Chu
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Jamie Hirata
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Michael Wenger
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Franck Morschhauser
Honoraria - Bayer; Celgene; Gilead Sciences; Mundipharma; Spectrum Pharmaceuticals
Research Funding - Genentech (Inst)
Travel, Accommodations, Expenses - Genentech